KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insulet (PODD) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to 16.66%.

  • Insulet's EBIT Margin rose 4700.0% to 16.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.32%, marking a year-over-year increase of 19100.0%. This contributed to the annual value of 14.91% for FY2024, which is 19500.0% up from last year.
  • As of Q3 2025, Insulet's EBIT Margin stood at 16.66%, which was up 4700.0% from 18.66% recorded in Q2 2025.
  • In the past 5 years, Insulet's EBIT Margin ranged from a high of 20.87% in Q4 2023 and a low of 8.92% during Q2 2022
  • Over the past 5 years, Insulet's median EBIT Margin value was 12.66% (recorded in 2023), while the average stood at 11.29%.
  • As far as peak fluctuations go, Insulet's EBIT Margin surged by 191200bps in 2021, and later tumbled by -189100bps in 2022.
  • Quarter analysis of 5 years shows Insulet's EBIT Margin stood at 16.15% in 2021, then crashed by -61bps to 6.36% in 2022, then surged by 228bps to 20.87% in 2023, then decreased by -12bps to 18.29% in 2024, then dropped by -9bps to 16.66% in 2025.
  • Its EBIT Margin stands at 16.66% for Q3 2025, versus 18.66% for Q2 2025 and 15.61% for Q1 2025.